How Sponsors Can Leverage New Technologies To Lower Trial Costs

By Robert Goldman and Justin Rudolph, ALCOA Consulting, LLC

Clinical trial costs, particularly in data management and monitoring, represent significant financial burdens for biotech sponsors. Traditional reliance on full-service contract research organizations (CROs) often ties sponsors to established processes that may overlook innovative, cost-saving opportunities. This study introduces the “CRIO Model,” a lean and efficient approach that integrates site-facing technologies, specifically Clinical Research IO's (CRIO) eSource platform, to streamline trial operations. By enabling direct data capture (DDC), the CRIO Model minimizes source transcription, reduces data queries, and shifts monitoring from on-site to remote modalities, thereby enhancing productivity and compliance. CROs, sponsors, and research sites alike benefit from the enhanced efficiency that the CRIO Model provides with CRA productivity and resourcing, leading to faster timelines and ultimately driving a more sustainable and patient-focused clinical trial ecosystem.